EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced that its subsidiary closed a successful $8 million equity investment funding round led by a multibillion dollar healthcare company.

EMED Technologies是药物输送和创新输液治疗设备的全球领导者，宣布其子公司成功完成了一轮由一家数十亿美元的医疗保健公司领投的800万美元股权融资。

EMED Technologies is an industry leader in the design, manufacture, and distribution of cutting-edge medical devices. Our core mission is to empower patient independence by developing patient-centric systems that improve quality of life and are designed for mid to large volume subcutaneous infusions.

EMED Technologies 是设计、制造和分销尖端医疗设备的行业领导者。我们的核心使命是通过开发以患者为中心的系统来增强患者的独立性，这些系统旨在改善生活质量，并适用于中到大容量的皮下输液。

Since 1991 EMED Technologies has worked with patients, clinicians, and pharmaceutical companies to design, manufacture, distribute, and commercialize innovative drug delivery systems. EMED has consistently pushed the boundaries of medical technology, providing solutions that enhance patient safety, improve clinical outcomes, and simplify drug administration for both patients and healthcare professionals..

自1991年以来，EMED技术公司与患者、临床医生和制药公司合作，设计、制造、分销和推广创新的药物输送系统。EMED不断推动医疗技术的边界，提供增强患者安全、改善临床结果并简化患者和医疗专业人员药物管理的解决方案。